Total Payments
$821.61
2023 Payments
$27.11
Companies
11
Transactions
37
Medicare Patients
518
Medicare Billing
$81,178
Payment Breakdown by Category
Food & Beverage$798.85 (97.2%)
Education$22.76 (2.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $798.85 | 36 | 97.2% |
| Education | $22.76 | 1 | 2.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| INSYS Therapeutics Inc | $360.69 | 18 | $0 (2017) |
| Novocure Inc. | $245.26 | 7 | $0 (2020) |
| Collegium Pharmaceutical, Inc. | $58.60 | 3 | $0 (2017) |
| Bayer HealthCare Pharmaceuticals Inc. | $30.51 | 2 | $0 (2017) |
| Siemens Medical Solutions USA, Inc. | $27.11 | 1 | $0 (2023) |
| Regeneron Healthcare Solutions, Inc. | $21.45 | 1 | $0 (2019) |
| Janssen Biotech, Inc. | $17.96 | 1 | $0 (2018) |
| Monteris Medical Corporation | $16.70 | 1 | $0 (2019) |
| Lantheus Medical Imaging, Inc. | $15.54 | 1 | $0 (2017) |
| E.R. Squibb & Sons, L.L.C. | $14.71 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $27.11 | 1 | Siemens Medical Solutions USA, Inc. ($27.11) |
| 2020 | $21.02 | 1 | Novocure Inc. ($21.02) |
| 2019 | $83.19 | 5 | Regeneron Healthcare Solutions, Inc. ($21.45) |
| 2018 | $182.24 | 4 | Novocure Inc. ($164.28) |
| 2017 | $508.05 | 26 | INSYS Therapeutics Inc ($360.69) |
All Payment Transactions
37 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/02/2023 | Siemens Medical Solutions USA, Inc. | Varian Ethos Treatment Planning (Device) | Food and Beverage | In-kind items and services | $27.11 | General |
| Category: Oncology | ||||||
| 01/15/2020 | Novocure Inc. | Oncology (Device) | Food and Beverage | Cash or cash equivalent | $21.02 | General |
| Category: Optune | ||||||
| 10/30/2019 | Monteris Medical Corporation | Neuroblate (Device) | Food and Beverage | In-kind items and services | $16.70 | General |
| Category: Neuroblate | ||||||
| 05/16/2019 | Boston Scientific Corporation | GENERAL THERAPIES (Device) | Food and Beverage | In-kind items and services | $13.08 | General |
| Category: THERAPIES | ||||||
| 05/08/2019 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $21.45 | General |
| Category: ONCOLOGY | ||||||
| 04/26/2019 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $14.71 | General |
| Category: Oncology | ||||||
| 03/13/2019 | Novocure Inc. | Oncology (Device) | Food and Beverage | Cash or cash equivalent | $17.25 | General |
| Category: Optune | ||||||
| 12/04/2018 | Janssen Biotech, Inc. | Erleada (Drug), DARZALEX | Food and Beverage | In-kind items and services | $17.96 | General |
| Category: Oncology | ||||||
| 03/19/2018 | Novocure Inc. | Oncology (Device) | Food and Beverage | Cash or cash equivalent | $120.48 | General |
| Category: Optune | ||||||
| 02/22/2018 | Novocure Inc. | Oncology (Device) | Education | Cash or cash equivalent | $22.76 | General |
| Category: Optune | ||||||
| 02/08/2018 | Novocure Inc. | Oncology (Device) | Food and Beverage | Cash or cash equivalent | $21.04 | General |
| Category: Optune | ||||||
| 12/01/2017 | INSYS Therapeutics Inc | SUBSYS (Drug) | Food and Beverage | In-kind items and services | $21.67 | General |
| Category: Breakthrough Cancer Pain | ||||||
| 10/02/2017 | INSYS Therapeutics Inc | SUBSYS (Drug) | Food and Beverage | In-kind items and services | $6.25 | General |
| Category: Breakthrough Cancer Pain | ||||||
| 09/15/2017 | INSYS Therapeutics Inc | SUBSYS (Drug) | Food and Beverage | In-kind items and services | $21.32 | General |
| Category: Breakthrough Cancer Pain | ||||||
| 08/24/2017 | INSYS Therapeutics Inc | SUBSYS (Drug) | Food and Beverage | In-kind items and services | $21.44 | General |
| Category: Breakthrough Cancer Pain | ||||||
| 08/23/2017 | Lantheus Medical Imaging, Inc. | Definity (Drug) | Food and Beverage | In-kind items and services | $15.54 | General |
| Category: Contrast Agent | ||||||
| 08/16/2017 | Collegium Pharmaceutical, Inc. | XTAMPZA ER (Drug) | Food and Beverage | Cash or cash equivalent | $19.79 | General |
| Category: opioid analgesic | ||||||
| 08/11/2017 | INSYS Therapeutics Inc | SUBSYS (Drug) | Food and Beverage | In-kind items and services | $17.39 | General |
| Category: Breakthrough Cancer Pain | ||||||
| 07/05/2017 | INSYS Therapeutics Inc | SUBSYS (Drug) | Food and Beverage | In-kind items and services | $24.65 | General |
| Category: Breakthrough Cancer Pain | ||||||
| 06/29/2017 | Novocure Inc. | Optune (Device) | Food and Beverage | Cash or cash equivalent | $23.64 | General |
| Category: Oncology | ||||||
| 06/14/2017 | Collegium Pharmaceutical, Inc. | Xtampza ER (Drug) | Food and Beverage | Cash or cash equivalent | $21.58 | General |
| Category: Opioid Analgesic | ||||||
| 05/24/2017 | Bayer HealthCare Pharmaceuticals Inc. | Stivarga (Drug), Nexavar | Food and Beverage | In-kind items and services | $18.18 | General |
| Category: Oncology | ||||||
| 05/16/2017 | INSYS Therapeutics Inc | SUBSYS (Drug) | Food and Beverage | In-kind items and services | $22.86 | General |
| Category: Breakthrough Cancer Pain | ||||||
| 05/12/2017 | INSYS Therapeutics Inc | SUBSYS (Drug) | Food and Beverage | In-kind items and services | $24.43 | General |
| Category: Breakthrough Cancer Pain | ||||||
| 04/27/2017 | INSYS Therapeutics Inc | SUBSYS (Drug) | Food and Beverage | In-kind items and services | $24.89 | General |
| Category: Breakthrough Cancer Pain | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 9 | 229 | 440 | $218,163 | $38,735 |
| 2020 | 11 | 289 | 526 | $234,023 | $42,443 |
Total Patients
518
Total Services
966
Medicare Billing
$81,178
Procedure Codes
20
All Medicare Procedures & Services
20 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 77427 | Radiation treatment management, 5 treatments | Facility | 2021 | 55 | 132 | $153,384 | $21,897 | 14.3% |
| 77014 | Ct scan guidance for insertion of radiation therapy fields | Facility | 2021 | 31 | 100 | $15,500 | $3,954 | 25.5% |
| 77263 | Management of radiation therapy, complex | Facility | 2021 | 25 | 25 | $12,129 | $3,686 | 30.4% |
| 77290 | Management of radiation therapy, simulation, complex | Facility | 2021 | 27 | 28 | $8,708 | $1,943 | 22.3% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 12 | 12 | $6,684 | $1,932 | 28.9% |
| 77300 | Calculation of radiation therapy dose | Facility | 2021 | 22 | 67 | $8,241 | $1,921 | 23.3% |
| 77334 | Radiation treatment devices, design and construction, complex | Facility | 2021 | 11 | 22 | $5,390 | $1,167 | 21.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 18 | 21 | $3,507 | $1,131 | 32.2% |
| 77280 | Management of radiation therapy simulation, simple | Facility | 2021 | 28 | 33 | $4,620 | $1,104 | 23.9% |
| 77427 | Radiation treatment management, 5 treatments | Facility | 2020 | 43 | 132 | $153,384 | $22,041 | 14.4% |
| 77263 | Management of radiation therapy, complex | Facility | 2020 | 25 | 27 | $13,099 | $4,071 | 31.1% |
| 77014 | Ct scan guidance for insertion of radiation therapy fields | Facility | 2020 | 30 | 79 | $12,245 | $3,012 | 24.6% |
| 77300 | Calculation of radiation therapy dose | Facility | 2020 | 27 | 78 | $9,594 | $2,278 | 23.7% |
| 77290 | Management of radiation therapy, simulation, complex | Facility | 2020 | 25 | 29 | $9,019 | $2,095 | 23.2% |
| 77280 | Management of radiation therapy simulation, simple | Facility | 2020 | 47 | 58 | $8,120 | $1,950 | 24.0% |
| 77334 | Radiation treatment devices, design and construction, complex | Facility | 2020 | 17 | 33 | $8,085 | $1,797 | 22.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 30 | 40 | $6,680 | $1,590 | 23.8% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Facility | 2020 | 11 | 11 | $6,127 | $1,532 | 25.0% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Facility | 2020 | 22 | 26 | $4,342 | $1,173 | 27.0% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Facility | 2020 | 12 | 13 | $3,328 | $904.60 | 27.2% |
About Daniel Bernad
Daniel Bernad is a Radiation Oncology healthcare provider based in Burbank, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/09/2015. The National Provider Identifier (NPI) number assigned to this provider is 1740658681.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Daniel Bernad has received a total of $821.61 in payments from pharmaceutical and medical device companies, with $27.11 received in 2023. These payments were reported across 37 transactions from 11 companies. The most common payment nature is "Food and Beverage" ($798.85).
As a Medicare-enrolled provider, Bernad has provided services to 518 Medicare beneficiaries, totaling 966 services with total Medicare billing of $81,178. Data is available for 2 years (2020–2021), covering 20 distinct procedure/service records.
Ad
Practice Information
- Specialty Radiation Oncology
- Location Burbank, CA
- Active Since 09/09/2015
- Last Updated 05/20/2024
- Taxonomy Code 2085R0001X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1740658681
Products in Payments
- SUBSYS (Drug) $360.69
- Oncology (Device) $202.55
- Optune (Device) $42.71
- Xtampza ER (Drug) $38.81
- Stivarga (Drug) $30.51
- Varian Ethos Treatment Planning (Device) $27.11
- LIBTAYO (Biological) $21.45
- XTAMPZA ER (Drug) $19.79
- Erleada (Drug) $17.96
- Neuroblate (Device) $16.70
- Definity (Drug) $15.54
- OPDIVO (Biological) $14.71
- GENERAL THERAPIES (Device) $13.08
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.